TY - JOUR
T1 - Time-resolved CT angiography for the detection and classification of endoleaks
AU - Sommer, Wieland H.
AU - Becker, Christoph R.
AU - Haack, Mareike
AU - Rubin, Geoffrey D.
AU - Weidenhagen, Rolf
AU - Schwarz, Florian
AU - Nikolaou, Konstantin
AU - Reiser, Maximilian F.
AU - Johnson, Thorsten R.
AU - Clevert, Dirk A.
PY - 2012
Y1 - 2012
N2 - Purpose: To assess the feasibility and diagnostic performance of time-resolved computed tomographic (CT) angiography in the detection and classification of endoleaks after endovascular aortic aneurysm repair (EVAR) in high-risk patients. Materials and Methods: The study was approved by our ethics committee. Written informed consent was obtained from all participating patients. Fifty-four patients (42 male and 12 female patients; mean age, 70.9 years ± 9.3 [standard deviation]) with either thoracic (n = 8) or abdominal (n = 46) aortic aneurysms treated with a stent-graft were prospectively included. The patients were examined with a time-resolved CT angiographic protocol consisting of 12 low-dose phases (80 kVp; 120 mAs [effective]; scan range, 27 cm), with 60 mL of iomeprol. Patients with abdominal aneurysm repair also underwent contrast material-enhanced (CE) ultrasonography (US). The time delay between contrast enhancement within the stent lumen and the endoleak was measured. Effective radiation dose was calculated from the scanner protocols. Measures of diagnostic performance for the detection of endoleaks were calculated for time-resolved CT angiography, with CE US serving as the reference standard. Results: All time-resolved CT angiographic data sets were diagnostic. Mean effective radiation dose was 14.6 mSv. Four thoracic and 19 abdominal endoleaks were identified by using time-resolved CT angiography. Seventeen of 19 abdominal endoleaks were confirmed with CE US. This rate resulted in a sensitivity of 94%, a specificity of 93%, a positive predictive value of 89%, and a negative predictive value of 96% for time-resolved CT angiography after abdominal EVAR. Type I endoleaks showed significantly earlier mean peak contrast enhancement (0.28 second ± 0.83) compared with that for type II endoleaks (9.17 seconds ± 3.59, P < .0001). Conclusion: Time-resolved CT angiography with 12 low-dose phases is feasible for patients after thoracic and abdominal EVAR. The protocol approximates the radiation dose of standard triphasic protocols. Its dynamic information differentiates types of endoleaks and shows high diagnostic performance.
AB - Purpose: To assess the feasibility and diagnostic performance of time-resolved computed tomographic (CT) angiography in the detection and classification of endoleaks after endovascular aortic aneurysm repair (EVAR) in high-risk patients. Materials and Methods: The study was approved by our ethics committee. Written informed consent was obtained from all participating patients. Fifty-four patients (42 male and 12 female patients; mean age, 70.9 years ± 9.3 [standard deviation]) with either thoracic (n = 8) or abdominal (n = 46) aortic aneurysms treated with a stent-graft were prospectively included. The patients were examined with a time-resolved CT angiographic protocol consisting of 12 low-dose phases (80 kVp; 120 mAs [effective]; scan range, 27 cm), with 60 mL of iomeprol. Patients with abdominal aneurysm repair also underwent contrast material-enhanced (CE) ultrasonography (US). The time delay between contrast enhancement within the stent lumen and the endoleak was measured. Effective radiation dose was calculated from the scanner protocols. Measures of diagnostic performance for the detection of endoleaks were calculated for time-resolved CT angiography, with CE US serving as the reference standard. Results: All time-resolved CT angiographic data sets were diagnostic. Mean effective radiation dose was 14.6 mSv. Four thoracic and 19 abdominal endoleaks were identified by using time-resolved CT angiography. Seventeen of 19 abdominal endoleaks were confirmed with CE US. This rate resulted in a sensitivity of 94%, a specificity of 93%, a positive predictive value of 89%, and a negative predictive value of 96% for time-resolved CT angiography after abdominal EVAR. Type I endoleaks showed significantly earlier mean peak contrast enhancement (0.28 second ± 0.83) compared with that for type II endoleaks (9.17 seconds ± 3.59, P < .0001). Conclusion: Time-resolved CT angiography with 12 low-dose phases is feasible for patients after thoracic and abdominal EVAR. The protocol approximates the radiation dose of standard triphasic protocols. Its dynamic information differentiates types of endoleaks and shows high diagnostic performance.
UR - http://www.scopus.com/inward/record.url?scp=84862490520&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84862490520&partnerID=8YFLogxK
U2 - 10.1148/radiol.12111217
DO - 10.1148/radiol.12111217
M3 - Article
C2 - 22623699
AN - SCOPUS:84862490520
SN - 0033-8419
VL - 263
SP - 917
EP - 926
JO - Radiology
JF - Radiology
IS - 3
ER -